Business Wire

IBC Best Conference Paper Award Recognises Advances in Artificial Intelligence

Jaa

In a year when artificial intelligence and machine learning became a very hot topic in the media industry, the IBC Best Conference Paper Award goes to a team from BBC R&D which has investigated practical applications. The award is made to the technical paper which, according to the team of peer reviewers, delivers not just the most significant new research, but does so in an accessible way.

The paper, ‘AI in production: video analysis and machine learning for expanded live events coverage’, will be presented at midday on Sunday 16 September as part of a new initiative at IBC2018 – ‘Tech Talks’. ‘Tech Talks’ ensures that the highly respected technical papers remain an integral part of IBC and its conference, bringing the latest ideas to all delegates in a fresh and accessible form.

Talking of the new innovation, Dr Nick Lodge, executive producer of technical sessions in the conference, said “Senior technologists and researchers who have been responsible for original and thought-provoking advances in media technology will talk about their own work, and audiences will have the rare opportunity to question these world experts.

“The technologies that impact the media industry are broad,” he added. “This year’s ‘Tech Talks’ will cover emerging areas like artificial intelligence, virtual and augmented reality, 5G and blockchain.”

In the award-winning paper a team of BBC researchers covering a wide range of skills, under project lead Mike Evans, discuss a project known as ‘Ed’. This prototype system is used to create near-live content with minimal crew. An example might be a set of three unmanned 4K cameras, from which ‘Ed’ would produce a number of properly framed HD pictures, cutting between them as appropriate.

“The point of the work is to allow coverage of more events, to reach places we otherwise could not reach,” Mike Evans said. “With conventional production we cover only about six of the nearly 100 places music is performed at the Glastonbury Festival, for example, or just a tiny fraction of the 50,000 performances in 300 venues at the Edinburgh Fringe.”

“But with ‘Ed’ we can reach many more of these and do so with production techniques which are much less intrusive for the event itself,” he explained. “This technology will be suitable not just for major production companies like the BBC, but for a whole range of use cases, like minor sports which need to increase visibility, and even vloggers who want to improve their online presence.”

Dr Paul Entwistle, Chair of the IBC Technical Papers Committee which provides careful peer review of the many papers proposed for IBC, said “The detail in this paper is absolutely fascinating. The team has developed an artificial intelligence system that understands the rhythms and cadences that make for professional video production. This was validated by research to see how well ‘Ed’ performs compared with a real director, and how the audience perceived the viewing experience.”

The authors winning this year’s IBC Best Conference Paper are Craig Wright (who will be presenting it at IBC), Jack Allnut, Rosie Campbell, Michael Evans, Ronan Forman, James Gibson, Stephen Jolly, Lianne Kerlin, Zuzanna Lechelt, Graeme Phillipson and Matthew Shotton, all from BBC R&D. They will be presented with the award as part of the IBC Awards Ceremony, on Sunday evening 16 September at 18:30 in the Auditorium.

The ceremony will see the presentation of all of IBC’s awards, including the International Honour for Excellence. Attendance is free for all IBC visitors.

## ENDS ##

Notes to Editors:

For more information about IBC2018 visit: show.ibc.org

About IBC
IBC is the world’s most influential media, entertainment and technology show. It attracts 57,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state-of-the-art electronic media and entertainment technology.

IBC2018 Dates
Conference: 13 - 17 September 2018

Exhibition: 14 - 18 September 2018

For more information about IBC2018 visit: show.ibc.org/

Contact information

IBC
Louise Wells, Bubble Agency
E: louisew@bubbleagency.com
T: +44 7718 985 252

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00Tiedote

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme